Sorry don't agree:
The share price and its growth versus that of Perpetual has every relevance. I invest to make money and get a good overall return.
You cannot assume that arrow or New Hope were just a lucky guess. The Milner's have acted very conservatively in the interests of shareholders.
Today I receive a letter from the proposed director nominated at the instance of Perpetual who suggests unlocking the franking credits. What a joke Perpetual may well get a benefit of cash and no extra tax but I pay more than 30% so the money will cause me to increase my tax burden. The super will be fine but then I have to invest in other things. How does his first comment help minorities who dont have a top tax bracket of 30% or is he just there to put pressure for Perpetual to unlock value for a corporate. These guys do make long term investments and have performed now we are being asked to ignore there superior performance as luck. Sorry but they made the luck and I think the Brickworks investments in plant and acquisitions will create wealth for the future. This share had no GFC rights issues and gearing issues and that was as a direct result of holding cash. This is a share to keep in the bottom drawer and has replaced my banking shares as the world has changed.
By the way I wonder who paid for the prospective director to send letters to everyone - what is he going to add top this board and he doesn't track how the companies he was a director of has faired does he. Looks more like a job application than anything.
- Forums
- ASX - By Stock
- SOL
- Ann: Letter to Shareholders
SOL
washington h soul pattinson & company limited
Add to My Watchlist
0.22%
!
$41.69

Ann: Letter to Shareholders , page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$41.69 |
Change
-0.090(0.22%) |
Mkt cap ! $15.33B |
Open | High | Low | Value | Volume |
$41.90 | $42.18 | $41.69 | $21.69M | 518.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2879 | $41.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$41.96 | 2092 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24 | 41.600 |
1 | 300 | 41.280 |
1 | 13 | 41.050 |
1 | 100 | 41.010 |
5 | 733 | 41.000 |
Price($) | Vol. | No. |
---|---|---|
42.000 | 153 | 1 |
42.190 | 260 | 2 |
42.400 | 800 | 2 |
42.420 | 29 | 2 |
42.500 | 388 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SOL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online